We conducted a retrospecti ve study to compare the sensitivity and specificity of traditional palpation-guided fin e-n eedl e aspiration biopsy (FNA B) pe rforme d by clinicians and pathologists with that of image-guided FNAB performed by radiologists fo r the evaluation of thyroid nodules. We reviewed the medical records of89 patients who hadundergon e thyroidFNAB andsubsequent surgical excision andpathology. Ofthis group, 58 patients had undergon epalpationguided FNAB pe rformed by a clin ician, 20 had undergon e palpation-guided FNA B p erform ed by a patholog ist, and 11 had undergone image-gu ided FNAB performed by a radiologist. The sensitivity of the three techniques was 86, 100, and 1DO%, respectively, and the specificity was 78, 94, and 44 %; there were no statistically significant differences in sensitivity or specificity amon g the three groups. Our data indicate that FNAB of the thyroid can be p erform ed with equal reliability by clini cians, pathologists, and radiolog ists.
Introduction
The reported incidence ofclinically evident thyroid nodules in North America ranges from 4 to 7%.1 The mal ignancy rate of palpable thyroid nodules is less than 5%.2,3 Th e evaluation of thes e nodules includes radionuclide scanning, ultrasonography, and fine-needle aspiration biopsy (FNAB). FNAB has become accepted as a reliable tool for the investigation of thyroid nodul es.
The sens itivity of palpation-guided thyroid FNABs has been reported to range from 65 to 98%, with specificity ranging from 72 to 100%.4.8Over the past decade, there has been an increasing trend tow ard the use of ima ge-guided FNAB for the evaluation ofhead and neck lesions, includ ing thyroid nodules.t" Ultrasonographic guidance is the mo st popular imaging mod ality for this purpose, but computed tomography (CT) has been used , as well. The sensitivity (60 to 100%) and specificity (87 to 100% ) ofimage-guided thyroid FNAB are also relatively high, and this technique yields a high rate of adequ ate samples (96%).' ·6. 8, 9 Image guidance is increasingly being used in patients who have small or nonpalpable lesions , incidentalomas, and les ions in difficult-to-access locations, as well as in patients whose previous FNABs were nondiagnostic .P:"
In view of the increasing use of image-guided FNAB performed by radiologists, we set out to determine whether the results they obtain are significantly different from the results obtained by palpation-guided FNAB performed by clinicians and pathologists.
Patients and methods
We retrospectively reviewed the medical records of 484 patients who had unde rgone FNAB of a thyroid nodul e between Aug. 1, 1993, and Aug. 31 , 1999, at Norton Hospital, an affiliate of the University of Louisville (Ky.) School of Medicine. The vast majority of these FNABs (89%) had been palpation-guided.
By cross-referencin g pathology records, we learned that 89 of these patients had undergone subsequent surgical excision (thyroid lobectomy) and pathologic examination. This group was made up of 36 men and 53 women, aged 19 to 77 years (mean: 55.4). The mean nodule size was 2.8 cm . Th e records of these patients allowed us to compare the ir preoperative FNAB results with the subsequent pathologic find ings.
The FNAB techniques used at our institution were sim ilar to those used in othe r studies." Clinicians evaluated the ir own samples, which were subm itted in the appropriate fixati ve solution. FNAB aspirates obtained by radiologists and pathologists were assessed for adequacy of content at the time of aspiration. Additional samples were obtained when specimens did not contain sati sfactory material for analysis.
We then perfo rmed a data analysis to calculate the sens itivity and specificity ofpalpation-guided and image-guided FNABs . Sensitivity was calculated by div iding the number oftrue-posit ive (TP) results by the numberoftrue pos itives plus the number of false-negative (FN ) results-that is, sensitivity = TP/(TP + FN). Specificity was calculated by divid ing the numb er of true-negative (TN) resu lts by the number oftrue nega tives plus the number offalse-pos itive (FP) results-that is, spec ificity = TN/(TN + FP). The chisquare (X 2 ) test and analysis of variance (ANOVA) were used to compare the data." The pos itive predictive value (PPV) was calculated by dividin g the total numb er of true positives by the total numb er of all positive tests-that is, PPV = TP/(TP + FP). An FNA B result was consid ered to be positive if it was interpreted as either malignant or suspicio us and negative if it was interpreted as benign . The inclusio n of suspicio us FNA Bs in the positive group was considere d app ropr iate because the aspirations were performed in order to identify patients who were candidates for definitive histologic analysis (excisional biopsy-thyroid lobectomy). No ndiagnostic FNABs were exclu ded from the calculat ions.
Results
Of89 patients, 58 (65%) had undergone palpation-guided FNAB performed by a clinician, 20 (22%) had undergone palpation-gu ided FNAB performed by a pathologist, and I I ( 12%) had undergo ne image-guided FNA B performed by a radiologist (tab le).
Clinician group. Cl inic ian-performed FNAB indicated that 26 of the 58 specimens (45%) were benign, 4 (7%) were malignant, 21 (36%) were suspicious, and 7 (12%) were nond iagnos tic. Surgical patho logy revealed that 46 (79%) were benign and 12 (21%) were malignant. The 12 ma lignancies included 7 papi llary carcinomas, 3 Hurthle cell carc inomas , and 2 follicular carcino mas . Two malignancies were incidental findings . One case involved the detection ofa microscopic focus ofpapillary carc inoma at a site away from the lesion samp led; the other tumor was a Hurthle cell carcinoma that also was located apart from the lesion sampled. The sensitivity ofclinici an-p erformed FNA B was 86% , the spec ificity was 78%, and the PPV was 48%.
Pathologist group. Of the 20 pathologist-performed FNABs, 12 (60%) we re benign, 4 (20%) were malignant, 2 ( 10%) were suspicious, and 2 ( 10%) were nondiagnostic. On surgical pathology, 15 (75%) were benign and 5 (25%) were malignant. Th e malignancies included 4 pap illary carcinomas and I medullary carcinoma.The sensitivity was 100%, the speci ficity was 94%, and the PPV was 83%.
Radiologist group. On image-guided FNA B, 4 of the I I specimens (36%) were benign, I (9%) was malignant , and 6 (55%) were sus pic ious. There were no nondiagnostic FNABs in this group. Surgical pathology identified 9 as ben ign (82%) and 2 as malignant ( 18%). Both ofthe malignancies were papillary carcinomas. The sensitivity, specificity, and PPV were 100, 44 , and 29%, respectively.
Statistical analysis. According to the X 2 test andAN OVA, there were no statistically significant differences among the three gro ups wit h respect to sens itivity or specificity (p = 0.215).
Discussion
Traditionally, the work-up and diagnosis ofthyroid nodules has been base d on the resul ts of palpation-gu ided FNA B. The goa l of FNA B is to identify which patients with thyroid nodules are at increased risk of thyro id malign ancy and therefore wi ll requi re a subsequent surg ical biopsy. Using this technique, the inc idence of malignancy in surgical speci mens has increased from 14 to 29%. 7Thi s higher yie ld of malignancy was accomplished by redu cing the numb er of patients who are candidates for excisio nal biopsy (thyro id lobectomy). Pat ients with clea rly benign FNAB pathology are not candidates for exci sio nal biop sy and are placed on observation stat us. Th is redu ced the tota l number of patients who undergo excisional biopsy. While palpation-gu ided FNA B has long been the standard , image-guide d FNA B with ultrasonograph y or CT has beco me increasi ngly popular."!' The advantages of image -guided FNA B include its ability to eva luate lesions that are diffic ult to identi fy on palpation, incl uding small lesions, lesions that have a large cystic component , deep or posterior masses, and substernal masses. It ca n also detect incide nta l nodules and provide additiona l information on nodu les that previously yie lded nondiagnostic material on FNAB. Image guidance also identifies blood vessels in the thyroi d and otherwise aids in opti mizi ng the localization of a biopsy site. Fina lly, it a llows for verification of the needle position within the mass.
Th e sensitivities of the three types ofFNAB assessed in our study-86% for palpation-guid ed FNAB by clini cians and 100% each for palpation-guid ed FNAB by path ologists and image-guid ed FNA B by radiolog ists-were not significantly different, and they correlate well with data in previously published reports.":" Likewise, the X 2 test and AN OYA did not indicate any statis tically significant difference among the specificities of the three types of FNA B, whic h ranged from 44 to 94 %.
The practice of classifying a suspicious FNA B finding as a pos itive res ult is controversial, and it results in a much higher specificity than wo uld otherwi se be the case . Yet the purpose of FNA B is not on ly to identify pat ients wit h clearly positive findings for malignancy, but to also identify those whose findings warrant a high index ofsuspicion for ma ligna ncy. Therefore, we consider the inclusion ofsuspicio us res ults as pos itive findi ngs to be clinically valid.
There were no nondiagnostic or inadequ ate speci mens amo ng our sma ll sample of image-guided FNABs. We consider the low nondi agnostic or inade quate spec imen rate for image-guid ed FNAB (0%) as the maj or adva ntage of this approach ove r the clini cian and pathologist palpation-guid ed rates (12 and 10%, respectively). Based on Volume 84, Number 6 this findi ng and on the high sensitivity of image-guided FNAB , we predict that an image -guided FNA B team approach, in which precise need le placement is performed by a radio logist or surgeon and the specimen's adequacy is immediately verified by a pathologist, will gradua lly rep lace pa lpatio n-g uided FNAB in many clinical settings. The prese nce ofa cytopathology tech nician ora pathologist duri ng FNA B has been show n to increase the proportion of diag nostic samples. ' One arguable limit ation of our study was the lack of a strict protocol. We believe that our study design represents a more acc urate reflection of the normal clin ical pract ice environment than a protocol conducted unde r rigid controls. The FNAB s in this study were obtained by a numb er of clinic ians, pathologists, and radiologists. Whil e the techn iques they emp loyed were ge nerally consistent, they were not tightly contro lled in terms ofthe exact number of aspirations that were obtained from eac h patient. Similarly, there were no strict criteria to follow when determining the adequacy of a specimen. In eac h situation, they used their bes t ju dgment.
Obviously,pathologists have an adva ntage in determini ng whet her a sample is adequate, whi le cl inicians simp ly base their decision on a visual assessment of the specimen. We do not suggest that the clinicians ' met hod is the best way ofjudging the adequacy ofa sample; we only suggest that this method reflects widespread curre nt practice. Under optimal circumsta nces , a specific and detailed protocol wo uld exp licitly define the technical meth odology for obta ining and eva luating FNA B spec imens, but this is not prac tica l in everyday practice.
An unambi gu ous lim itation of our study was the sma ll number of patients in each of the three gro ups.
In conc lusion, our data indic ate that FNA B of the thyroid can be perform ed with equal reliability by a clinician, patho logis t, or radiol ogist. We did not find any statistically significa nt differenc es among the three groups in terms of sensit ivity and specificity. However, as image-guided FNA B becom es more popul ar and data on more patient s beco me ava ilable, a statis tically sig nifican t differe nce may yet emerge.
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the excised mass obtained from our patient was xanthogranulomatous inflammation , although the mass did contain small areas of residual Warthin's tumor. In the case of the patient who had the preexisting pleomorphic adenoma, there was a long interval (-15 yr) between the resection of the pleomorphic adenoma and the development of the xanthogranulomatous tissue reaction.11. 12 A comparison of these 3 cases suggests that the development of a xanthogranulomatous tissue react ion in the parotid gland may be the result of a duct obstruction, a mech anism similarto the outflow obstruction implicated in the development of xanthogranulomatous pyelonephritis, cholecystitis, and appendicitis. The duct obstruction in these cases of parotid gland involvement could have been the result of a variety of mechanisms, including a reaction to the FNAB , extravasation of the contents ofthe Warthin 's tumor, infection, or postsurgical scarring.
Xanthogranulomatous sialadenitis can be difficult to diagnose, particularly at the time of frozen -section evaluation . The spindle cell proliferation that accompanies the xanthogranulomatous inflammation could be confused with a mesenchymal neoplasm such as a low-grade sarcoma. In our case , the accompanying inflammatory infiltrate suggested a reactive/inflammatory process. The absence ofthe Warthin's tumor component in the material submitted for frozen-section analysis further complicated interpretation.
The reporting of additional cases of xanthogranulomatous sialadenitis may help elucidate the mechanism of its development.
